72.19.Z - Other research and experimental development on natural sciences and engineering
22.29.Z - Manufacture of other plastic products
32.50.Z - Manufacture of medical and dental instruments and supplies
62.01.Z - Computer programming activities
71.12.Z - Engineering activities and related technical consultancy
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
74.10.Z - Specialised design activities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -2 | -6,9 | -14,6 | -111 |
EBITDA | -1,8 | -5,1 | -11,6 | -126,7 |
Short time liabilities | 2,9 | 4,6 | 12,4 | 167,5 |
Equity capital | 8,7 | 13,9 | 10,3 | -25,9 |
Operating profit (EBIT) | -1,9 | -6,7 | -13,7 | -104 |
Assets | 15,1 | 24,7 | 29,7 | 20,4 |
Net profit (loss) | -2 | -6,9 | -14,6 | -111 |
Cash | 1,8 | 0,8 | 4,7 | 473,9 |
Net income from sale | 0 | 0 | 0 | -∞ |
Liabilities and provisions for liabilities | 6,4 | 10,8 | 19,4 | 80,6 |
Working assets | 3,5 | 7,9 | 9,4 | 18,8 |
Depreciation | 0 | 1,6 | 2,1 | 32,4 |
% | % | % | p.p. | |
Profitability of capital | -23,2 | -49,7 | -141,5 | -91,8 |
Equity capital to total assets | 57,5 | 56,5 | 34,7 | -21,8 |
Gross profit margin | -89 573,1 | |||
EBITDA Margin | -70 852,4 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 276 335 | -2 147 207 313 |
Current financial liquidity indicator | 0.5693145394325256 | 0.7511143684387207 | 0.4920392632484436 | -0,3 |
Net dept to EBITDA | -0.09234754741191864 | -0.4315647780895233 | -0.515778660774231 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane